Episode Details

In this episode of The BioHub Podcast, Max sits down with Dr. Atta Behfar, Co-Founder of Rion and Professor of Regenerative Medicine at Mayo Clinic.

Atta’s work at Mayo led to a key discovery that became the foundation for Rion, a clinical-stage company developing exosome-based therapeutics through its Purified Exosome Product (PEP) platform.

In this conversation, Atta shares the story behind that discovery, how it translated into a company, and the potential of cell-free regenerative medicine to make advanced biologics more accessible to patients.

We also discuss Rion’s progress in wound healing, how the team has been built, and what’s next for their pipeline.

A fascinating look at how breakthrough science becomes real therapies.